Get the Stockscreener App
9.03
0.11%
0.010
Leonabio Inc stock is traded at $9.03, with a volume of 37,410.
It is up +0.11% in the last 24 hours and up +55.42% over the past month.
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).
See More
Previous Close:
$9.02
Open:
$9.34
24h Volume:
37,410
Relative Volume:
0.70
Market Cap:
$84.30M
Revenue:
-
Net Income/Loss:
$-37.72M
P/E Ratio:
-1.196
EPS:
-7.5501
Net Cash Flow:
$-52.35M
1W Performance:
-7.67%
1M Performance:
+55.42%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$8.88
$9.525
1-Week Range:
$8.70
$11.52
52-Week Range:
$4.21
$14.21
Leonabio Inc Stock (LONA) Company Profile
Name
Leonabio Inc
Sector
Industry
Phone
(425) 620-8501
Address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Compare LONA vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LONA
Leonabio Inc
|
9.03 | 84.21M | 0 | -37.72M | -52.35M | -7.5501 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Leonabio Inc Stock (LONA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-19-26 | Upgrade | Mizuho | Neutral → Outperform |
| Sep-19-24 | Downgrade | Mizuho | Outperform → Neutral |
| Sep-04-24 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-04-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-04-24 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| Aug-19-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-17-22 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Jun-23-22 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-23-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-23-22 | Downgrade | Stifel | Buy → Hold |
| May-10-22 | Initiated | BTIG Research | Buy |
| Apr-21-22 | Initiated | Berenberg | Buy |
| Dec-15-21 | Initiated | Goldman | Neutral |
| Oct-13-20 | Initiated | Goldman | Buy |
| Oct-13-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-13-20 | Initiated | Jefferies | Buy |
| Oct-13-20 | Initiated | Stifel | Buy |
View All
Leonabio Inc Stock (LONA) Latest News
LeonaBio, Inc. Adopts 2026 Equity Incentive Plan and Amends Certificate of Incorporation – SEC 8-K Filing March 2026 - Minichart
LeonaBio shareholders approve equity plan and increase in authorized shares - Investing.com India
Form 8K LeonaBio Inc For: 19 March - Investing.com
LeonaBio Expands Share Authorization to Support Future Financing - TipRanks
LeonaBio (ATHA) wins approval for 2026 equity plan and major share increase - Stock Titan
LONA: LeonaBio, Inc.Options Chain - Zacks Investment Research
LeonaBio, Inc. (prev. ATHA) (LONA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
[DEFR14A] LeonaBio, Inc. Revised Proxy Statement - Stock Titan
Renninger, LeonaBio CFO, sells $4.9k in LONA stock - Investing.com Nigeria
Renninger, LeonaBio CFO, sells $4.9k in LONA stock By Investing.com - Investing.com South Africa
LeonaBio CEO Litton sells $27,687 in shares By Investing.com - Investing.com Australia
LeonaBio CEO Litton sells $27,687 in shares - Investing.com South Africa
LeonaBio (ATHA) CEO converts 22,254 RSUs and sells shares for taxes - Stock Titan
LeonaBio (LONA) CMO covers RSU tax bill with share sale - Stock Titan
LeonaBio (NASDAQ: ATHA) files to sell 22,254 shares after RSU lapse - Stock Titan
Athira Pharma (LONA) 10K Form and SEC Filings 2026 $LONA - MarketBeat
Cantor Fitzgerald initiates Leona Bio stock with overweight rating By Investing.com - Investing.com Australia
LeonaBio initiated with an Overweight at Cantor Fitzgerald - TipRanks
Cantor Fitzgerald Initiates Coverage on LeonaBio With Overweight Rating - marketscreener.com
Cantor Fitzgerald initiates Leona Bio stock with overweight rating - Investing.com UK
LONA Technical Analysis & Stock Price Forecast - Intellectia AI
LONA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LeonaBio Inc expected to post a loss of 85 cents a shareEarnings Preview - TradingView
LeonaBio, Inc. (prev. ATHA) (LONA) Stock Price Today | Live Chart & News - Traders Union
LeonaBio Shares Rise After Mizuho Securities Upgrade - marketscreener.com
LeonaBio (LONA) Receives Upgrade to Outperform by Mizuho | LONA Stock News - GuruFocus
Mizuho upgrades LeonaBio stock rating on breast cancer drug potential By Investing.com - Investing.com South Africa
Mizuho upgrades LeonaBio stock rating on breast cancer drug potential - Investing.com
Mizuho Securities Initiates LeonaBio(LONA.US) With Buy Rating, Announces Target Price $10 - 富途牛牛
LeonaBio (ATHA) proxy asks investors to back warrant share issuances and 2026 equity plan - stocktitan.net
LeonaBio appoints Mark Kubik as chief business officer By Investing.com - Investing.com Nigeria
Leonabio, Inc. Announces the Appointment of Mark F. Kubik as Chief Business Officer - marketscreener.com
LeonaBio (LONA) Names Mark Kubik as New Chief Business Officer - GuruFocus
LeonaBio appoints Mark Kubik as chief business officer - Investing.com
LeonaBio, Inc. Appoints Mark F. Kubik as Chief Business Officer to Drive Business Development Strategy - Quiver Quantitative
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer - marketscreener.com
Biopharma deal veteran to drive LeonaBio’s Phase 3 breast cancer drug - Stock Titan
Leonabio Inc files for offering of up to 58.5 million shares of common stock by the selling stockholders - marketscreener.com
Leonabio Inc Files For Offering Of Up To 58.5 Million Shares Of Common Stock By The Selling Stockholders - TradingView
What is the current Price Target and Forecast for LeonaBio, Inc. (LONA) - Zacks Investment Research
symbol__ Stock Quote Price and Forecast - CNN
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker "LONA" - Investing News Network
LONA Stock Price and Chart — NASDAQ:LONA - TradingView
Athira Pharma (ATHA) Options to Be Delisted on January 12th - GuruFocus
LONA Stock Price, News & Analysis - Stock Titan
Athira Pharma Rebrands as LeonaBio, Refocusing on Oncology - TipRanks
Leonabio Inc Stock (LONA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):